Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	K48-linked polyubiquitin modification-dependent protein binding	UBQLN4 RNF31 MINDY1	1.20e-04	10	204	3	GO:0036435
GeneOntologyMolecularFunction	extracellular matrix structural constituent	DCN SSPOP COL14A1 HSPG2 TNC LAMA5 ENAM COL18A1 TNXB	1.40e-04	188	204	9	GO:0005201
GeneOntologyMolecularFunction	collagen binding	ITGA2 DCN COL14A1 HSPG2 CSPG4 TNXB	1.81e-04	81	204	6	GO:0005518
GeneOntologyMolecularFunction	polyubiquitin modification-dependent protein binding	UBQLN4 WDR81 OTUD7B RNF31 MINDY1	3.39e-04	59	204	5	GO:0031593
GeneOntologyCellularComponent	microtubule organizing center	CCDC81 DENND1C SPAG8 BIRC6 CNTROB MAGI2 STARD9 CCNA1 HERC2 MTUS2 FNIP2 ROCK2 CDC42BPG E2F1 SPECC1 SMTN CCNE1 MAPK15 NINL ZFYVE26 CSPP1 PIK3R5 HTT	4.03e-05	919	206	23	GO:0005815
Domain	LRR_8	LRRC39 PODNL1 PIDD1 DCN LRG1 PXDNL PKD1 TSKU LRRC27 SLITRK5 LRCH4	2.51e-06	171	201	11	PF13855
Domain	LRR_TYP	LRRC39 PODNL1 PIDD1 DCN LRG1 PXDNL PKD1 TSKU LRRC27 SLITRK5 LRCH4	3.51e-06	177	201	11	SM00369
Domain	Leu-rich_rpt_typical-subtyp	LRRC39 PODNL1 PIDD1 DCN LRG1 PXDNL PKD1 TSKU LRRC27 SLITRK5 LRCH4	3.51e-06	177	201	11	IPR003591
Domain	LRR	LRRC39 PODNL1 PIDD1 DCN LRG1 PXDNL PKD1 TSKU LRRC27 SLITRK5 LRCH4	1.18e-05	201	201	11	PS51450
Domain	ConA-like_dom	COL14A1 RANBP10 HSPG2 FAT4 RNF135 LAMA5 TRIM7 COL18A1 CSPG4 LRBA RFPL3	2.63e-05	219	201	11	IPR013320
Domain	Laminin_G	COL14A1 HSPG2 FAT4 LAMA5 COL18A1 CSPG4	3.66e-05	58	201	6	IPR001791
Domain	LamG	HSPG2 FAT4 LAMA5 COL18A1 CSPG4	1.06e-04	44	201	5	SM00282
Domain	LRR_1	LRRC39 PODNL1 PIDD1 DCN LRG1 PXDNL TSKU LRRC27 SLITRK5 LRCH4	1.35e-04	219	201	10	PF00560
Domain	ZU5	UNC5B PIDD1 ANK2	1.39e-04	10	201	3	PS51145
Domain	Leu-rich_rpt	LRRC39 PODNL1 PIDD1 DCN LRG1 PXDNL PKD1 TSKU LRRC27 SLITRK5 LRCH4	1.77e-04	271	201	11	IPR001611
Domain	L_dom-like	LRRC39 PODNL1 INSRR PIDD1 DCN LRG1 PXDNL PKD1 TSKU LRRC27 SLITRK5 LRCH4	2.37e-04	328	201	12	IPR032675
Domain	ZU5	UNC5B PIDD1 ANK2	2.51e-04	12	201	3	PF00791
Domain	ZU5_dom	UNC5B PIDD1 ANK2	2.51e-04	12	201	3	IPR000906
Domain	Growth_fac_rcpt_	EPHB6 INSRR KAZALD1 HSPG2 FAT4 TNC LAMA5 TNXB	2.92e-04	156	201	8	IPR009030
Domain	-	EPHB6 UNC5B INSRR OSCAR SIRPB1 PXDNL SPACA6 ASTN2 COL14A1 KAZALD1 PLXNA1 SIGLEC12 HSPG2 TIMD4 KALRN TNC TNXB IL9R	3.07e-04	663	201	18	2.60.40.10
Domain	Ig-like_fold	EPHB6 UNC5B INSRR OSCAR SIRPB1 PXDNL SPACA6 ASTN2 COL14A1 KAZALD1 PLXNA1 SIGLEC12 HSPG2 TIMD4 KALRN TNC TNXB IL9R	6.43e-04	706	201	18	IPR013783
Domain	LRRNT	PODNL1 DCN PXDNL PKD1 TSKU SLITRK5	6.68e-04	98	201	6	IPR000372
Domain	LRRNT	PODNL1 DCN PXDNL PKD1 TSKU SLITRK5	6.68e-04	98	201	6	SM00013
Domain	Death_domain	UNC5B PIDD1 ANK2 MADD	7.22e-04	38	201	4	IPR000488
Domain	DEATH_DOMAIN	UNC5B PIDD1 ANK2 MADD	7.22e-04	38	201	4	PS50017
Domain	LAM_G_DOMAIN	HSPG2 FAT4 LAMA5 CSPG4	7.22e-04	38	201	4	PS50025
Domain	-	LRRC39 PODNL1 PIDD1 DCN LRG1 PXDNL PKD1 TSKU LRRC27 SLITRK5 LRCH4	7.41e-04	321	201	11	3.80.10.10
Domain	Laminin_G_2	HSPG2 FAT4 LAMA5 CSPG4	8.79e-04	40	201	4	PF02210
Domain	BROMODOMAIN_2	BRPF3 KMT2A BRWD1 PBRM1	9.65e-04	41	201	4	PS50014
Domain	Bromodomain	BRPF3 KMT2A BRWD1 PBRM1	1.06e-03	42	201	4	IPR001487
Domain	BROMO	BRPF3 KMT2A BRWD1 PBRM1	1.06e-03	42	201	4	SM00297
Domain	-	BRPF3 KMT2A BRWD1 PBRM1	1.06e-03	42	201	4	1.20.920.10
Domain	FYrich_C	KMT2A KMT2D	1.13e-03	5	201	2	IPR003889
Domain	FYrich_N	KMT2A KMT2D	1.13e-03	5	201	2	IPR003888
Domain	FYRC	KMT2A KMT2D	1.13e-03	5	201	2	SM00542
Domain	FYRN	KMT2A KMT2D	1.13e-03	5	201	2	SM00541
Domain	FYRN	KMT2A KMT2D	1.13e-03	5	201	2	PF05964
Domain	FYRC	KMT2A KMT2D	1.13e-03	5	201	2	PF05965
Domain	FYRC	KMT2A KMT2D	1.13e-03	5	201	2	PS51543
Domain	FYRN	KMT2A KMT2D	1.13e-03	5	201	2	PS51542
Domain	Cadherin_CS	FAT4 DSG3 PCDHB7 PCDHGA12 DCHS1 CDH15	1.17e-03	109	201	6	IPR020894
Domain	CADHERIN_1	FAT4 DSG3 PCDHB7 PCDHGA12 DCHS1 CDH15	1.40e-03	113	201	6	PS00232
Domain	Cadherin	FAT4 DSG3 PCDHB7 PCDHGA12 DCHS1 CDH15	1.40e-03	113	201	6	PF00028
Domain	FN3	EPHB6 INSRR ASTN2 COL14A1 KALRN TNC TNXB IL9R	1.44e-03	199	201	8	PS50853
Domain	CADHERIN_2	FAT4 DSG3 PCDHB7 PCDHGA12 DCHS1 CDH15	1.47e-03	114	201	6	PS50268
Domain	-	FAT4 DSG3 PCDHB7 PCDHGA12 DCHS1 CDH15	1.47e-03	114	201	6	2.60.40.60
Pathway	KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P27_CELL_CYCLE_G1_S_N00482	CCNA1 E2F1 CCNE1	7.87e-05	9	141	3	M47578
Pathway	REACTOME_ECM_PROTEOGLYCANS	ITGA2 DCN HSPG2 TNC LAMA5 TNXB	1.11e-04	76	141	6	M27219
Pathway	BIOCARTA_SKP2E2F_PATHWAY	CCNA1 E2F1 CCNE1	1.12e-04	10	141	3	MM1384
Pathway	BIOCARTA_SKP2E2F_PATHWAY	CCNA1 E2F1 CCNE1	1.12e-04	10	141	3	M6031
Pathway	KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P27_CELL_CYCLE_G1_S_N00264	CCNA1 E2F1 CCNE1	1.52e-04	11	141	3	M47492
Pathway	BIOCARTA_G1_PATHWAY	ABL1 CCNA1 E2F1 CCNE1	1.63e-04	28	141	4	M648
Pathway	BIOCARTA_G1_PATHWAY	ABL1 CCNA1 E2F1 CCNE1	1.88e-04	29	141	4	MM1364
Pathway	REACTOME_LAMININ_INTERACTIONS	ITGA2 HSPG2 LAMA5 COL18A1	2.15e-04	30	141	4	M27216
Pathway	REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM	DCN HSPG2 HGSNAT GUSB CSPG4	2.57e-04	57	141	5	M692
Pathway	SA_REG_CASCADE_OF_CYCLIN_EXPR	CCNA1 E2F1 CCNE1	2.60e-04	13	141	3	M3686
Pathway	KEGG_AXON_GUIDANCE	EPHB6 ABL1 UNC5B PLXNA1 ROCK2 EFNA5 EFNB2	3.12e-04	129	141	7	M5539
Pathway	KEGG_MEDICUS_REFERENCE_P27_CELL_CYCLE_G1_S	CCNA1 E2F1 CCNE1	3.29e-04	14	141	3	M47427
Pathway	REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G1_CELL_CYCLE_ARREST	CCNA1 E2F1 CCNE1	3.29e-04	14	141	3	M27635
Pathway	REACTOME_EPH_EPHRIN_SIGNALING	EPHB6 ROCK2 KALRN EFNA5 EFNB2	4.76e-04	65	141	5	MM14911
Pathway	REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING	EPHB6 ROCK2 KALRN EFNB2	4.90e-04	37	141	4	MM15022
Pathway	PID_INTEGRIN1_PATHWAY	ITGA2 TNC LAMA5 COL18A1 CSPG4	5.11e-04	66	141	5	M18
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ABL1 NUP85 BIRC6 CNTROB FASN CD2BP2 PKD1 MTMR3 KAZALD1 HERC2 DNMBP PLXNA1 PRRC2B ANKRD13D DPH2 RANBP10 HSPG2 KALRN LAMA5 TWNK ZBTB42 TFE3 MADD TRIM7 CCNE1 NCOR1 KMT2D GAREM2 TRAPPC12 CDK13 CSPG4 NINL PCNX1 AKAP13 ZFYVE26 LRBA MAPKBP1 ZNF839 HTT	3.82e-19	1105	209	39	35748872
Pubmed	K48- and K63-linked ubiquitin chain interactome reveals branch- and length-specific ubiquitin interactors.	CDCA3 UBQLN4 BIRC6 FBXO30 OTUD7B PRMT5 ABCD3 HERC2 DNMBP MTUS2 ANKRD13D RNF31 TWNK DDI2 MADD KMT2D RASSF8 YME1L1 MINDY1	5.45e-09	604	209	19	38803224
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	CDCA3 GOLM2 TSC1 BIRC6 CNTROB ARID1B NCAPG CD2BP2 MTMR3 ABCD3 HERC2 PRRC2B TMEM51 HID1 PTPN21 MADD NCOR1 MTMR6 KMT2D ZNF512 PPP6R2 CSPP1 YME1L1	1.04e-07	1049	209	23	27880917
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	DCN SSPOP COL14A1 HSPG2 TNC COL18A1 TNXB	1.19e-07	64	209	7	22261194
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	NUP85 BIRC6 CNTROB NCAPG PRMT5 KIAA1958 KMT2A CHD6 MOV10 KMT2D PBRM1 PAXBP1 GTF3C2 CDK13 ACIN1	1.90e-07	469	209	15	27634302
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	ACD UBQLN4 SPAG8 BPIFA1 SSPOP CNTROB CHD6 PRRC2B ANKRD13D HSPG2 FAT4 RNF31 KALRN NCOR1 EXOC5 MAPKBP1 PPP6R2	1.92e-07	608	209	17	16713569
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	POLR1G OTUD7B FASN ANAPC1 KIAA1958 KMT2A DNMBP WDR44 ROCK2 NELFB SMTN NCOR1 KMT2D PAXBP1 FAM13A CDK13 TKT ACIN1 TJAP1	2.65e-07	774	209	19	15302935
Pubmed	Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.	DCN LRG1 COL14A1 HSPG2 TNC LAMA5 COL18A1 CSPG4 TNXB	2.73e-07	146	209	9	27068509
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	EPHB6 INSRR SLCO3A1 SPAG8 MTMR3 CHD6 HERC2 TNC GRM4 MTMR6 MAPK15 CDK13 PCNX1 LSM14A	2.99e-07	420	209	14	28065597
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	DCN ARID1B COX5A CHD6 PRRC2B FAT4 DRP2 TNC TFE3 NCOR1 KMT2D PBRM1 DNAH12 TRAPPC12 ZNF512 CSPP1 YME1L1	3.75e-07	638	209	17	31182584
Pubmed	N6-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation.	ABL1 OSCAR INO80D ZNF846 DPH2 NUP43 CSPG4 PCNX1 AKAP13 MINDY1	8.70e-07	217	209	10	34048709
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RIPOR2 TSC1 MAGI2 STARD9 MTMR3 NAV3 CHD6 PRRC2B FNIP2 FRMPD1 MADD ACIN1 MAPKBP1	1.29e-06	407	209	13	12693553
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	MRM1 POLR1G INO80D COX5A ANAPC1 SCOC PRMT5 ABCD3 KMT2A CHD6 HERC2 DNMBP MOV10 PCDHB7 LAMA5 TWNK SPECC1 COL18A1 PBRM1 PAXBP1 GTF3C2 CDK13 LRCH4 INTS9 LSM14A YME1L1	1.29e-06	1497	209	26	31527615
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	FASN ARID1B NCAPG ANAPC1 KMT2A PRRC2B WDR44 NCOR1 MTMR6 KMT2D GTF3C2 ACIN1 QSER1 LRBA HTT	1.37e-06	549	209	15	38280479
Pubmed	BioID reveals an ATG9A interaction with ATG13-ATG101 in the degradation of p62/SQSTM1-ubiquitin clusters.	CDCA3 UNC5B RPS6KC1 MTMR6 TRAPPC12 GUSB SLITRK5 TJAP1 LRBA AP4M1 HTT	1.40e-06	285	209	11	34369648
Pubmed	Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.	DCN COL14A1 HSPG2 TNC LAMA5 COL18A1 CSPG4 TNXB	1.71e-06	135	209	8	28675934
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	MCM6 POLR1G FASN WDR44 ROCK2 KALRN NELFB NCOR1 PBRM1 FAM13A GTF3C2 CDK13 ACIN1 AKAP13	2.51e-06	503	209	14	16964243
Pubmed	Proteomics characterization of extracellular space components in the human aorta.	DCN COL14A1 HSPG2 TNC LAMA5 COL18A1 TNXB	2.73e-06	101	209	7	20551380
Pubmed	Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.	ARRDC1 MCM6 FASN ANKRD13D DOCK2 HSPG2 LAMA5 EGR1 TRAPPC12	6.51e-06	214	209	9	22199357
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	WDR81 TSC1 SIRPB1 MAGI2 ANAPC1 HERC2 PRRC2B ROCK2 RANBP10 ANK2 KALRN SIPA1 GRM4 NCOR1 PBRM1 DCHS1 TJAP1 QSER1 PPP6R2	6.51e-06	963	209	19	28671696
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	RPS6KC1 PRMT5 NAV3 CHD6 HERC2 MTUS2 PRRC2B KALRN MADD NCOR1 PBRM1 LSM14A HTT	6.90e-06	475	209	13	31040226
Pubmed	Comprehensive Characterization of Tissues Derived from Animals at Different Regenerative Stages: A Comparative Analysis between Fetal and Adult Mouse Skin.	HSPG2 TNC COL18A1	7.36e-06	7	209	3	37174615
Pubmed	Myotubularin-related proteins 3 and 4 interact with polo-like kinase 1 and centrosomal protein of 55 kDa to ensure proper abscission.	ANAPC1 MTMR3 CARD14 MADD MTMR6 ACIN1 AP4M1 PPP6R2	8.31e-06	167	209	8	25659891
Pubmed	Mohawk promotes the maintenance and regeneration of the outer annulus fibrosus of intervertebral discs.	DCN COL14A1 TNC TNXB	8.51e-06	22	209	4	27527664
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	DCN SSPOP COL14A1 HSPG2 TNC LAMA5 COL18A1 TNXB	1.17e-05	175	209	8	28071719
Pubmed	Distinct gene loci control the host response to influenza H1N1 virus infection in a time-dependent manner.	HPS1 DNMBP RNF6	1.17e-05	8	209	3	22905720
Pubmed	Mice develop normally without tenascin.	HSPG2 TNC TNXB	1.17e-05	8	209	3	1383086
Pubmed	ik3-1/Cables is a substrate for cyclin-dependent kinase 3 (cdk 3).	CCNA1 E2F1 CCNE1	1.17e-05	8	209	3	11733001
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	GOLM2 SSPOP SPACA6 ASTN2 CHD6 RPS6KL1 CDC42BPG FRMPD1 COL18A1 EFNA5 EFNB2 FAM13A CDK13 LRRC27 TJAP1 AKAP13 LSM14A QSER1 LRBA ZNF839 ZNF512 PRDM15 CDH15 HTT	1.18e-05	1489	209	24	28611215
Pubmed	Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance.	ITGA2 HSPG2 TNC LAMA5 COL18A1	1.27e-05	50	209	5	23658023
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	CDCA3 WDR81 BCAT2 TSC1 RPS6KC1 ABCD3 PLXNA1 FNIP2 MADD TRAPPC12 LRCH4 LRBA YME1L1	1.29e-05	504	209	13	34432599
Pubmed	Functional proteomics mapping of a human signaling pathway.	UBQLN4 ARID1B PKD1 CHD6 HERC2 HSPG2 LAMA5 TWNK TSKU NCOR1 KMT2D PBRM1 CDK13 CSPG4	1.55e-05	591	209	14	15231748
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	NUP85 MCM6 RPS6KC1 ARID1B ANAPC1 ABCD3 NKTR HERC2 MOV10 NUP43 PBRM1 GTF3C2	1.62e-05	440	209	12	34244565
Pubmed	Loss of Cul1 results in early embryonic lethality and dysregulation of cyclin E.	CCNA1 E2F1 CCNE1	1.75e-05	9	209	3	10508527
Pubmed	Perlecan maintains microvessel integrity in vivo and modulates their formation in vitro.	HSPG2 COL18A1 CSPG4	1.75e-05	9	209	3	23320101
Pubmed	Human transcription factor protein interaction networks.	INO80D ARID1B COX5A CD2BP2 ABCD3 KMT2A CHD6 HERC2 PRRC2B MOV10 HSPG2 TWNK E2F1 TFE3 NCOR1 KMT2D PBRM1 MRPL15 GTF3C2 LSM14A QSER1 RASSF8 ZNF512	1.86e-05	1429	209	23	35140242
Pubmed	Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies.	UNC5B ASTN2 KALRN CREB5	2.32e-05	28	209	4	18839057
Pubmed	EphB signaling regulates target innervation in the developing and deafferented auditory brainstem.	EPHB6 EFNA5 EFNB2	2.49e-05	10	209	3	22021100
Pubmed	Integrin alpha6beta1-laminin interactions regulate early myotome formation in the mouse embryo.	MYF5 HSPG2 LAMA5	2.49e-05	10	209	3	16554364
Pubmed	In vitro nuclear interactome of the HIV-1 Tat protein.	NUP85 MCM6 NCAPG KMT2A PBRM1 RNF6 ACIN1 ZNF512	2.55e-05	195	209	8	19454010
Pubmed	Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation.	DCN HSPG2 TNC LAMA5 COL18A1 TNXB	2.75e-05	97	209	6	27559042
Pubmed	The COOH-terminal domain of huntingtin interacts with RhoGEF kalirin and modulates cell survival.	KALRN HTT	3.59e-05	2	209	2	29789657
Pubmed	The tenascin gene family in axon growth and guidance.	TNC TNXB	3.59e-05	2	209	2	9321695
Pubmed	Cholinergic deficits selectively boost cortical intratelencephalic control of striatum in male Huntington's disease model mice.	CHAT HTT	3.59e-05	2	209	2	36914640
Pubmed	ANAPC1 and SLCO3A1 are associated with nicotine dependence: meta-analysis of genome-wide association studies.	SLCO3A1 ANAPC1	3.59e-05	2	209	2	22377092
Pubmed	MLL1 promotes myogenesis by epigenetically regulating Myf5.	MYF5 KMT2A	3.59e-05	2	209	2	31840352
Pubmed	Nonstructural maintenance of chromatin condensin I complex subunit G promotes the progression of glioblastoma by facilitating Poly (ADP-ribose) polymerase 1-mediated E2F1 transactivation.	NCAPG E2F1	3.59e-05	2	209	2	37422706
Pubmed	Early growth response 1 and fatty acid synthase expression is altered in tumor adjacent prostate tissue and indicates field cancerization.	FASN EGR1	3.59e-05	2	209	2	22127986
Pubmed	Anguilla japonica lectin 1 delivery through adenovirus vector induces apoptotic cancer cell death through interaction with PRMT5.	PRMT5 E2F1	3.59e-05	2	209	2	26990556
Pubmed	Huntingtin-associated protein 1 (HAP1) binds to a Trio-like polypeptide, with a rac1 guanine nucleotide exchange factor domain.	KALRN HTT	3.59e-05	2	209	2	9285789
Pubmed	Set1 and MLL1/2 Target Distinct Sets of Functionally Different Genomic Loci In Vivo.	KMT2A KMT2D	3.59e-05	2	209	2	26711341
Pubmed	Cell surface chondroitin sulphate proteoglycan 4 (CSPG4) binds to the basement membrane heparan sulphate proteoglycan, perlecan, and is involved in cell adhesion.	HSPG2 CSPG4	3.59e-05	2	209	2	29462330
Pubmed	Validation of NG2 antigen in identifying BP-ALL patients with MLL rearrangements using qualitative and quantitative flow cytometry: a prospective study.	KMT2A CSPG4	3.59e-05	2	209	2	17851550
Pubmed	Regulation of the cyclin E gene by transcription factor E2F1.	E2F1 CCNE1	3.59e-05	2	209	2	8618861
Pubmed	Mll2 is required for H3K4 trimethylation on bivalent promoters in embryonic stem cells, whereas Mll1 is redundant.	KMT2A KMT2D	3.59e-05	2	209	2	24423662
Pubmed	Expression of cyclins A and E in melanocytic skin lesions and its correlation with some clinicopathologic features.	CCNA1 CCNE1	3.59e-05	2	209	2	22763964
Pubmed	Microarray-based identification of tenascin C and tenascin XB, genes possibly involved in tumorigenesis associated with neurofibromatosis type 1.	TNC TNXB	3.59e-05	2	209	2	17202312
Pubmed	Giant cadherins Fat and Dachsous self-bend to organize properly spaced intercellular junctions.	FAT4 DCHS1	3.59e-05	2	209	2	25355906
Pubmed	Distribution of tenascin-C and -X, and soft X-ray analysis of the mandibular symphysis during mandible formation in the human fetus.	TNC TNXB	3.59e-05	2	209	2	15455729
Pubmed	Tenascin variants: ligands and expression.	TNC TNXB	3.59e-05	2	209	2	7509489
Pubmed	The effects of tenascin C knockdown on trabecular meshwork outflow resistance.	TNC TNXB	3.59e-05	2	209	2	23882691
Pubmed	PRMT5 Promotes Cyclin E1 and Cell Cycle Progression in CD4 Th1 Cells and Correlates With EAE Severity.	PRMT5 CCNE1	3.59e-05	2	209	2	34168658
Pubmed	Genetic deletion or small-molecule inhibition of the arginine methyltransferase PRMT5 exhibit anti-tumoral activity in mouse models of MLL-rearranged AML.	PRMT5 KMT2A	3.59e-05	2	209	2	28663579
Pubmed	Association study of polymorphisms in the group III metabotropic glutamate receptor genes, GRM4 and GRM7, with schizophrenia.	GRM4 GRM7	3.59e-05	2	209	2	19351574
Pubmed	Tenascin-X expression in tumor cells and fibroblasts: glucocorticoids as negative regulators in fibroblasts.	TNC TNXB	3.59e-05	2	209	2	8856503
Pubmed	Deletion of the basement membrane heparan sulfate proteoglycan type XVIII collagen causes hypertriglyceridemia in mice and humans.	HSPG2 COL18A1	3.59e-05	2	209	2	21085708
Pubmed	Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney.	HSPG2 COL18A1	3.59e-05	2	209	2	12514129
Pubmed	E2F1 Induces tumor cell survival via nuclear factor-kappaB-dependent induction of EGR1 transcription in prostate cancer cells.	E2F1 EGR1	3.59e-05	2	209	2	19276347
Pubmed	CCNE1 and E2F1 Partially Suppress G1 Phase Arrest Caused by Spliceostatin A Treatment.	E2F1 CCNE1	3.59e-05	2	209	2	34769053
Pubmed	MCM6 promotes intrahepatic cholangiocarcinoma progression by upregulating E2F1 and enhancing epithelial-mesenchymal transition.	MCM6 E2F1	3.59e-05	2	209	2	37185675
Pubmed	Overexpression of EphB6 and EphrinB2 controls soma spacing of cortical neurons in a mutual inhibitory way.	EPHB6 EFNB2	3.59e-05	2	209	2	37149633
Pubmed	Decreased c-Abl activity in PC-3 and LNCaP prostate cancer cells overexpressing the early growth response-1 protein.	ABL1 EGR1	3.59e-05	2	209	2	24190424
Pubmed	Structure of the planar cell polarity cadherins Fat4 and Dachsous1.	FAT4 DCHS1	3.59e-05	2	209	2	36797229
Pubmed	Invasion of melanoma in double knockout mice lacking tenascin-X and tenascin-C.	TNC TNXB	3.59e-05	2	209	2	12359049
Pubmed	Localization of a binding site for the proteoglycan decorin on collagen XIV (undulin).	DCN COL14A1	3.59e-05	2	209	2	9252349
Pubmed	Mammalian cadherins DCHS1-FAT4 affect functional cerebral architecture.	FAT4 DCHS1	3.59e-05	2	209	2	25930014
Pubmed	Ephrin-B2 is a candidate ligand for the Eph receptor, EphB6.	EPHB6 EFNB2	3.59e-05	2	209	2	10648835
Pubmed	Melanotic Translocation Renal Cell Carcinoma With a Novel ARID1B-TFE3 Gene Fusion.	ARID1B TFE3	3.59e-05	2	209	2	28877054
Pubmed	The change in tenascin expression in mouse uterus during early pregnancy.	TNC TNXB	3.59e-05	2	209	2	9013311
Pubmed	c-Abl regulates early growth response protein (EGR1) in response to oxidative stress.	ABL1 EGR1	3.59e-05	2	209	2	16091742
Pubmed	PRMT5 promotes cancer cell migration and invasion through the E2F pathway.	PRMT5 E2F1	3.59e-05	2	209	2	32709847
Pubmed	Therapeutic targeting of the USP2-E2F4 axis inhibits autophagic machinery essential for zinc homeostasis in cancer progression.	MCM6 POLR1G CD2BP2 PRRC2B NUP43 LAMA5 NCOR1 COL18A1 ACIN1 LSM14A YME1L1	3.63e-05	403	209	11	35253629
Pubmed	Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	NAV3 FAM149B1 DNMBP FRMPD1 NINL PCNX1	3.65e-05	102	209	6	10231032
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	MCM6 TSC1 CNTROB MTUS2 TNC LAMA5 SIPA1 SPECC1 FAM13A NINL TJAP1 LSM14A MAPKBP1	3.86e-05	560	209	13	21653829
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	ACD UBQLN4 POLR1G INO80D COX5A ANAPC1 CD2BP2 KMT2A CHD6 NKTR NUP43 TFE3 NCOR1 KMT2D PBRM1 PAXBP1 GTF3C2 CDK13 ACIN1 INTS9 QSER1	3.89e-05	1294	209	21	30804502
Pubmed	Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.	DCN COL14A1 HSPG2 TNC LAMA5 COL18A1 TNXB	4.13e-05	153	209	7	25037231
Pubmed	A human MAP kinase interactome.	RIPOR2 FBXO30 NAV3 CHD6 NKTR HERC2 WDR44 WIPF1 MADD EGR1 AKAP13 ZNF839	4.26e-05	486	209	12	20936779
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	PIDD1 BIRC6 SSPOP RPS6KC1 DQX1 PRMT5 PKD1 ABCD3 CHD6 MROH9 CDC42BPG FAT4 NELFB DDI2 AKAP13	4.37e-05	736	209	15	29676528
Pubmed	Alpha9 and beta8 integrin expression correlates with the merger of the developing mouse eyelids.	ITGA2 TNC LAMA5	4.52e-05	12	209	3	10090148
Pubmed	Interplay of BAF and MLL4 promotes cell type-specific enhancer activation.	MYF5 KMT2D PBRM1	4.52e-05	12	209	3	33712604
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	BIRC6 CD2BP2 ASTN2 MOV10 DOCK2 ROCK2 RANBP10 NELFB CDK13 SLITRK5 ZNF512 PPP6R2	4.89e-05	493	209	12	15368895
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	CDCA3 NUP85 ARRDC1 GOLM2 CNTROB PRMT5 PKD1 BRWD1 ROCK2 MADD PPOX SMTN PTOV1 ADAMTS10 CDK13 TJAP1 LSM14A	4.91e-05	925	209	17	28986522
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	UBQLN4 BIRC6 FASN ANAPC1 ABCD3 KIAA1958 CHD6 NCOR1 KMT2D GTF3C2 LRBA	5.05e-05	418	209	11	34709266
Pubmed	The spatiotemporal expression pattern of Syndecans in murine embryonic teeth.	DCN HSPG2 COL18A1 CSPG4	5.10e-05	34	209	4	32220631
Pubmed	Deletions of Retinoblastoma 1 (Rb1) and Its Repressing Target S Phase Kinase-associated protein 2 (Skp2) Are Synthetic Lethal in Mouse Embryogenesis.	CCNA1 E2F1 CCNE1	5.85e-05	13	209	3	26966181
Pubmed	Histone-binding of DPF2 mediates its repressive role in myeloid differentiation.	BRPF3 NUP85 MRM1 MCM6 ARID1B PRMT5 NELFB TKT INTS9	5.88e-05	283	209	9	28533407
Pubmed	Genetic interaction mapping in mammalian cells using CRISPR interference.	INO80D KMT2A KMT2D PBRM1 INTS9	6.14e-05	69	209	5	28481362
Pubmed	Chondrocytes respond to an altered heparan sulfate composition with distinct changes of heparan sulfate structure and increased levels of chondroitin sulfate.	DCN HSPG2 COL18A1 CSPG4	7.16e-05	37	209	4	32201365
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	DCN COL14A1 HSPG2 TNC LAMA5 COL18A1 CSPG4	7.19e-05	167	209	7	22159717
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ABL1 MYLK3 STARD9 PRMT5 KMT2A DNMBP NELFB PTPN21 SPECC1 MADD PTOV1 FAM13A AKAP13 RASSF8 RNF180 CSPP1	7.22e-05	861	209	16	36931259
Interaction	TOP3B interactions	ABL1 NUP85 BIRC6 CNTROB FASN PRMT5 CD2BP2 PKD1 MTMR3 KAZALD1 HERC2 DNMBP PLXNA1 PRRC2B MOV10 ANKRD13D DPH2 RANBP10 HSPG2 KALRN LAMA5 TWNK ZBTB42 TFE3 MADD TRIM7 CCNE1 NCOR1 KMT2D GAREM2 TRAPPC12 CDK13 CSPG4 NINL ACIN1 PCNX1 AKAP13 ZFYVE26 LSM14A LRBA MAPKBP1 ZNF839 HTT	2.31e-10	1470	205	43	int:TOP3B
GeneFamily	Fibronectin type III domain containing	EPHB6 INSRR ASTN2 COL14A1 KALRN TNC TNXB	2.00e-04	160	135	7	555
GeneFamily	Guanylate cyclase receptors\|DENN/MADD domain containing	DENND1C FNIP2 MADD	8.30e-04	25	135	3	504
GeneFamily	Blood group antigens\|CD molecules\|Proteoglycans	HSPG2 CSPG4	1.13e-03	7	135	2	570
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	UNC5B PXDNL KAZALD1 SIGLEC12 HSPG2 KALRN	1.33e-03	161	135	6	593
GeneFamily	Ephrins	EFNA5 EFNB2	1.50e-03	8	135	2	546
GeneFamily	Glutamate metabotropic receptors\|Protein phosphatase 1 regulatory subunits	GRM4 GRM7	1.50e-03	8	135	2	281
GeneFamily	WD repeat domain containing\|BEACH domain containing	WDR81 LRBA	1.93e-03	9	135	2	1230
GeneFamily	Pseudoautosomal region 2	SPRY3 IL9R	2.39e-03	10	135	2	716
GeneFamily	WD repeat domain containing	WDR81 WDR44 BRWD1 NUP43 GTF3C2 LRBA MAPKBP1	3.56e-03	262	135	7	362
Coexpression	NABA_CORE_MATRISOME	PODNL1 DCN SSPOP LRG1 PXDNL COL14A1 HSPG2 TNC LAMA5 TSKU COL18A1 TNXB	2.36e-06	275	209	12	M5884
Coexpression	NABA_CORE_MATRISOME	PODNL1 DCN SSPOP LRG1 COL14A1 HSPG2 TNC LAMA5 TSKU COL18A1 TNXB	1.19e-05	270	209	11	MM17057
Coexpression	GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP	CDCA3 PIDD1 NCAPG KMT2A ROCK2 E2F1 CCNE1 PCNX1 CSPP1	2.73e-05	194	209	9	M7467
Coexpression	GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_UP	MTMR3 CCNA1 C1R HGSNAT PTOV1 DCHS1 NINL QSER1 ZNF512	2.96e-05	196	209	9	M7562
Coexpression	GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_UP	ARRDC1 MRM1 FASN HSD17B1 NELFB PCDHB7 MADD PTOV1 PCNX1	3.47e-05	200	209	9	M7207
Coexpression	GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_DN	RIPOR2 ITGA2 FBXO30 MTMR3 KIAA1958 MDFIC HID1 SPECC1 CSPG4	3.47e-05	200	209	9	M5679
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LRRC39 ABL1 UNC5B LRG1 SPACA6 NAV3 HSPG2 ANK2 TNC COL18A1 DLEU7	1.76e-09	190	209	11	f50b9814a1beac67dc042a8c27dfd085ceeda3a6
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LRRC39 ABL1 UNC5B LRG1 SPACA6 NAV3 HSPG2 ANK2 TNC COL18A1 DLEU7	1.76e-09	190	209	11	a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LRRC39 ABL1 UNC5B LRG1 SPACA6 NAV3 HSPG2 ANK2 TNC COL18A1 DLEU7	1.76e-09	190	209	11	57c136bf6d7feafb4a220877bed0cc8fdf314db2
ToppCell	NS-moderate-d_07-13-Lymphoid-NK\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CCDC168 DCN NAV3 C1R FAT4 COL18A1 CSPG4 DCHS1 RASSF8	1.50e-07	175	209	9	f6cd24d22f62469319f9d244e3e5de527d3d4d94
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	C2orf69 GOLM2 KMT2A BRWD1 E2F1 CREB5 PAXBP1 RNF6 SLITRK5	3.29e-07	192	209	9	d6f656be2698bd215717d35f4e7ab727c08c61e0
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 SLCO3A1 DCN MAGI2 PXDNL C1R COL14A1 ANK2 TNC	3.59e-07	194	209	9	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BNC2 DCN C1R COL14A1 FAT4 ANK2 WIPF1 TNC EGR1	4.63e-07	200	209	9	a4ec0e80f5422b91b85264a9bb74568dd577e285
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BNC2 DCN STARD9 NAV3 C1R COL14A1 FAT4 ANK2 TNXB	4.63e-07	200	209	9	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BNC2 DCN STARD9 NAV3 C1R COL14A1 FAT4 ANK2 TNXB	4.63e-07	200	209	9	0c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCell	Leuk-UTI-Lymphocyte-T_NK-dnT\|Leuk-UTI / Disease, Lineage and Cell Type	DENND1C ITGA2 SPAG8 ANAPC1 SIGLEC12 TIMD4 EFNA5 MINDY1	5.39e-07	149	209	8	53f145cf7089d948d41aa3c443e983e011826836
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ACD CRACR2B NCAPG ANAPC1 FRMPD1 E2F1 GAREM2 NINL	8.81e-07	159	209	8	2233fee5dcdb6c7dee5b1bd8efbc07d86b339927
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 MAGI2 PXDNL NAV3 ASTN2 COL14A1 TNC TNXB	2.23e-06	180	209	8	9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BNC2 XIRP1 MAGI2 C1R FAT4 TNC COL18A1 TNXB	2.23e-06	180	209	8	f2f6e83127a4a415e65c76a35efa8175fbd5b5d9
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BNC2 ABL1 DCN C1R ANK2 CREB5 EGR1 TNXB	2.74e-06	185	209	8	9faa35ceb89ccd2979072286f063687c9f846ce3
ToppCell	droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRC39 UNC5B CRACR2B SPACA6 NAV3 ANK2 COL18A1 DLEU7	2.74e-06	185	209	8	3a4ae836e882e8d29eb0a2dfab5677f10f2d365f
ToppCell	COVID-19-Fibroblasts-Adventitial_FB\|COVID-19 / group, cell type (main and fine annotations)	BNC2 DCN MAGI2 NAV3 C1R COL14A1 ANK2 TNXB	2.74e-06	185	209	8	a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCell	droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRC39 UNC5B CRACR2B SPACA6 NAV3 ANK2 COL18A1 DLEU7	2.74e-06	185	209	8	224f0b022c21dd40bf1f7503f00b3107ef958975
ToppCell	moderate-Lymphoid-NK\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	BNC2 DCN C1R FAT4 TNC CSPG4 DCHS1 RASSF8	2.74e-06	185	209	8	4979a787acbc9b4ca8defe91cc79b674e51af1bf
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	NUP85 NUP43 LAMA5 EGR1 NINL LRBA MAPKBP1 PRDM15	2.85e-06	186	209	8	77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	NUP85 NUP43 LAMA5 EGR1 NINL LRBA MAPKBP1 PRDM15	2.85e-06	186	209	8	13bc41c60fd628af31899a5e8b480e06cc4781be
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	BIRC6 INO80D ARID1B KMT2A NKTR FAM13A PCNX1 LRBA	3.09e-06	188	209	8	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	Control-Fibroblasts-Adventitial_FB\|Control / group, cell type (main and fine annotations)	BNC2 DCN NAV3 C1R COL14A1 ANK2 CREB5 TNXB	3.09e-06	188	209	8	706a26c372add839d947749f0521a0e1f5c9b0ec
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	XIRP1 MYLK3 PXDNL MTUS2 ANK2 KALRN CREB5 KLHL31	3.34e-06	190	209	8	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	LRRC39 MYLK3 PXDNL MTUS2 ANK2 KLHL31 EFNA5 AKAP13	3.47e-06	191	209	8	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 MAGI2 PXDNL ASTN2 COL14A1 TNC EFNA5 TNXB	3.47e-06	191	209	8	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	Basal_cells-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	BCAT2 ITGA2 DSG3 TNC LAMA5 TSKU COL18A1 SLITRK5	3.47e-06	191	209	8	a98915bad9a4a61dd4cbca798914849b805f4a19
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 SLCO3A1 DCN MAGI2 PXDNL COL14A1 ANK2 TNC	3.61e-06	192	209	8	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 SLCO3A1 DCN PXDNL C1R COL14A1 ANK2 TNC	3.61e-06	192	209	8	f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 SLCO3A1 DCN MAGI2 C1R COL14A1 ANK2 TNC	3.61e-06	192	209	8	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell\|Adult / Lineage, Cell type, age group and donor	BNC2 DCN NAV3 C1R COL14A1 ANK2 ADAMTS10 TNXB	3.61e-06	192	209	8	d21f0f577156f17c899b08871046a26b88aea011
ToppCell	Mesenchymal-matrix_fibroblast_2_cell\|World / Lineage, Cell type, age group and donor	BNC2 DCN NAV3 C1R COL14A1 FAT4 ANK2 TNXB	3.61e-06	192	209	8	a769158c49d2b208c4224d85e7ae68c85cc372ed
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 SLCO3A1 DCN MAGI2 PXDNL COL14A1 ANK2 TNC	3.61e-06	192	209	8	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 DCN MAGI2 PXDNL ASTN2 COL14A1 ANK2 TNC	3.75e-06	193	209	8	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	BNC2 DCN NAV3 C1R COL14A1 FAT4 ANK2 TNXB	3.75e-06	193	209	8	9ab47b360bee1d4f1092c2269e58acebe9584021
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 DCN MAGI2 PXDNL C1R COL14A1 ANK2 TNC	3.89e-06	194	209	8	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 SLCO3A1 DCN MAGI2 PXDNL COL14A1 ANK2 TNC	3.89e-06	194	209	8	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INSRR NKTR PRRC2B ANK2 HID1 MADD NCOR1 EGR1	3.89e-06	194	209	8	0b023de48ed8a550d169bbe954881eb04bf4f981
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	BNC2 ABL1 DCN NAV3 C1R ANK2 EGR1 TNXB	4.04e-06	195	209	8	ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BNC2 DCN NAV3 C1R COL14A1 FAT4 ANK2 TNXB	4.04e-06	195	209	8	f54bc4454270ff06e85596f98199372b50d0179f
ToppCell	Tracheal-10x3prime_v2-Stromal-Mesofibroblastic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	DCN FBXL18 C1R COL14A1 ANK2 ADAMTS10 PAXBP1 TNXB	4.36e-06	197	209	8	d7cef7881abd807a679432766ced609a6efd1067
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	BNC2 DCN MAGI2 NAV3 C1R COL14A1 KALRN TNC	4.36e-06	197	209	8	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	Tracheal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	DCN FBXL18 C1R COL14A1 ANK2 ADAMTS10 PAXBP1 TNXB	4.36e-06	197	209	8	20a5958512bdb99daeb8f4d244df53e4f048f879
ToppCell	Sepsis-URO-Others\|URO / Disease, condition lineage and cell class	ACD MCM6 NIBAN3 KIAA1958 RNF31 E2F1 DCHS1 INTS9	4.53e-06	198	209	8	6caab5266da666cfbe92ac1ace26ad2004e5aa09
ToppCell	Sepsis-URO-Others-RBC\|URO / Disease, condition lineage and cell class	ACD MCM6 NIBAN3 KIAA1958 RNF31 E2F1 DCHS1 INTS9	4.53e-06	198	209	8	d35e9d0952b3f7cd5d0d1a69bad2ae81af8eed50
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	BNC2 SLCO3A1 DCN PXDNL COL14A1 ANK2 TNC TNXB	4.70e-06	199	209	8	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	mLN-B_cell-B_cell_IgA_Plasma\|B_cell / Region, Cell class and subclass	SSPOP FNIP2 TNC TMEM51 HID1 ENAM SLITRK5 CDH15	4.70e-06	199	209	8	09494953bc7fff63cf2763ea89fca7abb97c186f
ToppCell	Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	DCN C1R COL14A1 HSPG2 ANK2 TNC CREB5 EFNA5	4.70e-06	199	209	8	40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	BNC2 DCN MAGI2 NAV3 COL14A1 FAT4 TNC TNXB	4.70e-06	199	209	8	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SLCO3A1 DCN PXDNL COL14A1 ANK2 TNC SLITRK5 TNXB	4.87e-06	200	209	8	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BNC2 DCN NAV3 C1R COL14A1 ANK2 CREB5 TNXB	4.87e-06	200	209	8	ad3fdcef895400f929f2ae12ff9bd85fd46adb3a
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BIRC6 ARID1B KMT2A NKTR PAXBP1 CDK13 ACIN1 AKAP13	4.87e-06	200	209	8	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Tracheal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BNC2 DCN STARD9 NAV3 C1R FAT4 ANK2 TNXB	4.87e-06	200	209	8	c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PODNL1 UNC5B DCN KAZALD1 TNC TSKU CSPG4 CDH15	4.87e-06	200	209	8	780d47f8eff630020dfae32218de495a7e9dbad6
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PODNL1 UNC5B DCN KAZALD1 TNC TSKU CSPG4 CDH15	4.87e-06	200	209	8	28dd127787a57276253548d1f030814b1af64481
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BNC2 DCN NAV3 C1R COL14A1 FAT4 ANK2 TNXB	4.87e-06	200	209	8	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BNC2 DCN STARD9 NAV3 C1R COL14A1 FAT4 TNXB	4.87e-06	200	209	8	3dd022e974fec7013ba18f333da63f58fbf2dd7c
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BNC2 DCN NAV3 C1R COL14A1 ANK2 EGR1 TNXB	4.87e-06	200	209	8	74e74123ea7bf38d337a3a0248a6a51437c6ab42
ToppCell	control-Plasmablast\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	NCAPG DQX1 ANK2 LAMA5 HID1 CCNE1 ENAM	1.32e-05	165	209	7	61063e0ce61bc92d5d1093be8279af03f650720b
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	INSRR DCN COL14A1 ANK2 TNC EFNA5 TNXB	1.32e-05	165	209	7	4e13fccd32029e2879e85f8966e582a46c09e4aa
ToppCell	droplet-Pancreas-Endocrine-18m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRC39 INSRR FNIP2 MADD PAXBP1 MAPK15 EGR1	1.37e-05	166	209	7	66026988509e39e41274fa0de738383219e8ff30
ToppCell	343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2\|343B / Donor, Lineage, Cell class and subclass (all cells)	MCM6 SIRPB1 MYLK3 CARD14 E2F1 RSPH3 DLEU7	1.43e-05	167	209	7	7efa0081e79f22b219eac64ffcaedb2179cde299
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	INSRR DCN COL14A1 PLXNA1 ANK2 TNC EFNA5	1.43e-05	167	209	7	fe3338f99f94c0dac37e3d649dfdce82e4a56022
ToppCell	droplet-Fat-Bat-18m-Myeloid-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C2orf69 B3GNT8 RANBP10 TMEM51 MADD INTS9 PPP6R2	1.48e-05	168	209	7	6fddc957a0503455d8c165862b5eb8e5fdb8a510
ToppCell	droplet-Fat-Bat-18m-Myeloid-myeloid_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C2orf69 B3GNT8 RANBP10 TMEM51 MADD INTS9 PPP6R2	1.48e-05	168	209	7	794035cb63353a7d02fd9939deb5b4d075c9d95a
ToppCell	droplet-Fat-Bat-18m-Myeloid\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C2orf69 B3GNT8 RANBP10 TMEM51 MADD INTS9 PPP6R2	1.48e-05	168	209	7	1e23b634f96e88b976a523ca1f3fc08f6fe9b239
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	C2orf69 NAV3 ASTN2 DPH2 ADAMTS10 GAREM2 LRRC27	1.72e-05	172	209	7	de4961f4037c439d3e0ec706a257b0ec17f4d5be
ToppCell	facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CHAT NIBAN3 SSPOP TIMD4 TRIM7 RNF180 PIK3R5	1.72e-05	172	209	7	48d0cfc37d1b1ae48ed8f8b2711abeb609d2bb6e
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Interstitial_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TIMD4 SPECC1 CREB5 MADD LRBA MAPKBP1 ZNF512	2.23e-05	179	209	7	6eb84fe9691ad40127b2d1f1c672428333c8fab4
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-lung_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TIMD4 SPECC1 CREB5 MADD LRBA MAPKBP1 ZNF512	2.23e-05	179	209	7	2c3abd646d2c8992e8ff76a824eab5beba8ba4c6
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 DCN MAGI2 HSD17B1 TNC EFNA5 TNXB	2.23e-05	179	209	7	02c90d8306016365ed811f0c63cfb3ac7b85464c
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 MAGI2 PXDNL NAV3 ASTN2 COL14A1 TNXB	2.31e-05	180	209	7	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDCA3 ZC3H12B NCAPG FBXL18 PLXNA1 TIMD4 MAPKBP1	2.39e-05	181	209	7	3fe648db1cb8326066d8bde3ca1287c5c9af19bd
ToppCell	NS-moderate-d_16-33-Lymphoid-NK\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	BNC2 BRINP1 DCN NAV3 C1R TNC DCHS1	2.48e-05	182	209	7	fb503f8ecd013f1f2161a5841572b57cfcddb6fa
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DCN NAV3 C1R COL14A1 TNC COL18A1 TNXB	2.48e-05	182	209	7	3dfa9187e9d2bab1d199079d29209c4648220ada
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	BNC2 DCN HSPG2 TNC SPECC1 EGR1 TNXB	2.48e-05	182	209	7	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	Basal\|World / shred by cell class for mouse tongue	BCAT2 LAMA5 GRM4 CREB5 COL18A1 CSPG4 TJAP1	2.57e-05	183	209	7	c6729a207526ff4aa48176207b9353176f631fea
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 KCNB2 MAGI2 TNC ADAMTS10 EFNA5 TNXB	2.57e-05	183	209	7	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NAV3 NKTR KALRN CREB5 SMTN EFNA5 TNXB	2.57e-05	183	209	7	4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	XIRP1 MYLK3 PXDNL MTUS2 ANK2 KLHL31 EFNA5	2.75e-05	185	209	7	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC5B ZC3H12B DCN ASTN2 COL14A1 TNC TNXB	2.75e-05	185	209	7	f814ec9d4ade717a0109398e9768d0d66f09317b
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC5B ZC3H12B DCN ASTN2 COL14A1 TNC TNXB	2.75e-05	185	209	7	40e958511790e84321da5ccf735f9974c06a0263
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	BNC2 DCN PXDNL TNC CREB5 EGR1 TNXB	2.75e-05	185	209	7	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D231\|Adult / Lineage, Cell type, age group and donor	BNC2 DCN NAV3 C1R COL14A1 ADAMTS10 TNXB	2.75e-05	185	209	7	fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC5B ZC3H12B DCN ASTN2 COL14A1 TNC TNXB	2.75e-05	185	209	7	5f2eeba80aff145e85cfd81e2890a155406badb9
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 CHAT PXDNL ASTN2 COL14A1 TNXB	2.77e-05	125	209	6	b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PXDNL ASTN2 ANK2 EFNA5 NINL LRBA RASSF8	2.85e-05	186	209	7	1850583d23903d08226aeb0edb3e07b0994330e4
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PXDNL ASTN2 ANK2 EFNA5 NINL LRBA RASSF8	2.85e-05	186	209	7	4dafc215c42e7949f932a3627359c107943b5d6b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SLCO3A1 STARD9 ROCK2 KALRN TNC SPECC1 CSPG4	2.95e-05	187	209	7	15d6e158562d7d85af3ceaf955439b379c8fce81
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SLCO3A1 STARD9 ROCK2 KALRN TNC SPECC1 CSPG4	2.95e-05	187	209	7	f62074b631fd45ad299c69d71b09267b04d656ee
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)\|368C / Donor, Lineage, Cell class and subclass (all cells)	CRACR2B NUP43 LAMA5 NINL LRBA MAPKBP1 PRDM15	2.95e-05	187	209	7	b827d9da7032bf051756ddf88352af922eb0f87b
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	CRACR2B NUP43 LAMA5 NINL LRBA MAPKBP1 PRDM15	2.95e-05	187	209	7	61c00604dda8b36a5c3eea6554e5601aa1b884f7
ToppCell	droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLCO3A1 LRG1 RPS6KL1 ANK2 SMTN COL18A1 DLEU7	3.05e-05	188	209	7	dc52dd2957be3f40001f0a56f3d9ac9d66ea466e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SLCO3A1 STARD9 ROCK2 KALRN TNC SPECC1 CSPG4	3.05e-05	188	209	7	32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081
ToppCell	COPD-Epithelial-Mesothelial\|Epithelial / Disease state, Lineage and Cell class	EPHB6 BNC2 DCN SPACA6 NAV3 C1R CREB5	3.05e-05	188	209	7	159d63ecc3653a7449fc6acefd6ef0464845260e
ToppCell	droplet-Lung-1m-Endothelial-lymphatic_endothelial\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLCO3A1 LRG1 RPS6KL1 ANK2 SMTN COL18A1 DLEU7	3.05e-05	188	209	7	2ef08313087e91985bcffc46c3798470cdeec49c
ToppCell	droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLCO3A1 LRG1 RPS6KL1 ANK2 SMTN COL18A1 DLEU7	3.05e-05	188	209	7	1f1604b6dc0a8ad0be3d9aac0bef448459c22465
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INSRR PRRC2B ANK2 MADD EFNA5 EGR1 AKAP13	3.05e-05	188	209	7	a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 SLCO3A1 DCN PXDNL C1R COL14A1 TNC	3.16e-05	189	209	7	e9d5e858e320c6e9913c1ea6a54967d21eda605f
ToppCell	moderate-Lymphoid-NK\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DCN C1R HSPG2 FAT4 TNC CSPG4 RASSF8	3.16e-05	189	209	7	22a19365782003c18ec8dddcdbfdaa82c4e330f6
ToppCell	droplet-Lung-LUNG-30m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYF5 INSRR DCN COL14A1 EFNA5 TNXB CDH15	3.16e-05	189	209	7	6b3b42d758b63a0df62310c34fa3bde421c1afd7
Computational	Neighborhood of RBM8A	BRPF3 FBXO30 MTMR3 KMT2A PRRC2B EXOC5 ZNF512	3.73e-05	81	123	7	GCM_RBM8A
Computational	Neighborhood of PRKCG	BCAT2 SIRPB1 COL14A1 GRM4 TFE3 MADD	7.92e-05	63	123	6	GCM_PRKCG
Computational	Neighborhood of SMARCD1	BCAT2 SIRPB1 COL14A1 GRM4 TFE3 MADD CSPG4	1.95e-04	105	123	7	GCM_SMARCD1
Computational	Neighborhood of ATM	BCAT2 SIRPB1 CDK13 HTT	2.34e-04	27	123	4	GCM_ATM
Computational	Neighborhood of UBE2N	BRPF3 FBXO30 MTMR3 KMT2A ASTN2 PRRC2B EXOC5 YME1L1	3.79e-04	154	123	8	GCM_UBE2N
Drug	Benzthiazide [91-33-8]; Down 200; 9.2uM; PC3; HT_HG-U133A	PIDD1 INO80D HPS1 ROCK2 MDFIC RNF6 TJAP1 PCNX1 AKAP13 AP4M1 RASSF8	2.11e-06	197	208	11	6607_DN
Drug	Butamben [94-25-7]; Down 200; 20.6uM; PC3; HT_HG-U133A	NAV3 PRRC2B RNF6 SLITRK5 TJAP1 AKAP13 LSM14A RASSF8 CSPP1 HTT	1.09e-05	191	208	10	5792_DN
Drug	Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A	SPAG8 HPS1 MTMR3 KAZALD1 PRRC2B HSPG2 E2F1 GSAP SMTN QSER1	1.25e-05	194	208	10	4804_DN
Drug	Vinpocetine [42971-09-5]; Up 200; 11.4uM; HL60; HG-U133A	MRM1 KAZALD1 FAM149B1 PRRC2B DPH2 TWNK E2F1 GSAP FAM13A TRAPPC12	1.36e-05	196	208	10	1557_UP
Drug	0173570-0000 [211245-44-2]; Down 200; 1uM; PC3; HT_HG-U133A	NAV3 DNMBP BRWD1 HSPG2 SIPA1 COL18A1 SLITRK5 PCNX1 AKAP13 CSPP1	1.36e-05	196	208	10	7391_DN
Drug	Diethylstilbestrol [56-53-1]; Down 200; 15uM; MCF7; HT_HG-U133A	PIDD1 HPS1 HSD17B1 E2F1 NCOR1 ZFYVE26 LSM14A AP4M1 PPP6R2 CSPP1	1.36e-05	196	208	10	3429_DN
Drug	Thioridazine hydrochloride [130-61-0]; Down 200; 9.8uM; HL60; HG-U133A	PIDD1 INO80D HPS1 PRRC2B DPH2 RANBP10 E2F1 PPOX CSPP1 PIK3R5	1.43e-05	197	208	10	1986_DN
Drug	Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A	SPAG8 DCN FBXL18 KMT2A RNF31 PTPN21 PPOX SMTN COL18A1 TJAP1	1.43e-05	197	208	10	3484_UP
Drug	Yohimbine hydrochloride [65-19-0]; Up 200; 10.2uM; HL60; HG-U133A	MRM1 DCN HPS1 WDR44 HGSNAT TRAPPC12 TJAP1 INTS9 PCNX1 ZFYVE26	1.43e-05	197	208	10	1763_UP
Drug	Clorgyline hydrochloride [17780-75-5]; Down 200; 13uM; HL60; HG-U133A	UNC5B MRM1 DENND1C E2F1 NCOR1 GTF3C2 EGR1 LRBA PIK3R5 HTT	1.43e-05	197	208	10	1604_DN
Drug	Mephenesin [59-47-2]; Down 200; 22uM; PC3; HT_HG-U133A	SPAG8 NKTR PRRC2B BRWD1 TMEM51 PTPN21 CCNE1 AKAP13 RASSF8 ZNF839	1.43e-05	197	208	10	7374_DN
Drug	iron acetate	ITGA2 DSG3 LRBA	1.47e-05	6	208	3	CID000018344
Drug	Zalcitabine [7481-89-2]; Down 200; 19uM; PC3; HT_HG-U133A	MRM1 NKTR BRWD1 FAT4 TNC GSAP SLITRK5 PCNX1 ZNF839 PPP6R2	1.49e-05	198	208	10	4215_DN
Drug	Metrizamide [31112-62-6]; Down 200; 5uM; PC3; HT_HG-U133A	PIDD1 INO80D KAZALD1 HSPG2 WIPF1 ARR3 FAM13A PCNX1 AKAP13 ZNF839	1.62e-05	200	208	10	4075_DN
Drug	hyaluronan	DCN COL14A1 HSPG2 DSG3 TNC LAMA5 TWNK TSKU COL18A1 GUSB TNXB	3.23e-05	263	208	11	CID000024759
Drug	diphenylacetylene	KMT2A GUSB AP4M1 YME1L1	4.35e-05	22	208	4	CID000010390
Drug	AC1N21PP	ITGA2 GRM4 GRM7	6.06e-05	9	208	3	CID004014619
Drug	Ipratropium bromide [22254-24-6]; Up 200; 9.8uM; HL60; HG-U133A	UNC5B HPS1 KMT2A PLXNA1 DPH2 TWNK NINL PCNX1 PPP6R2	7.72e-05	194	208	9	1769_UP
Drug	Probucol [23288-49-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A	EPHB6 PODNL1 SLCO3A1 DENND1C ITGA2 SPAG8 INO80D KMT2A HSPG2	8.03e-05	195	208	9	5261_UP
Drug	colchicine; Down 200; 1uM; SKMEL5; HG-U133A	MRM1 KMT2A WIPF1 TMEM51 TWNK TRAPPC12 ACIN1 MINDY1 HTT	8.03e-05	195	208	9	630_DN
Drug	dimethylamino)difluorophosphine	ITGA2 E2F1	8.31e-05	2	208	2	CID000136639
Drug	Bordeaux red	DSG3 TSKU	8.31e-05	2	208	2	CID005351791
Drug	Amprolium hydrochloride [137-88-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A	RIPOR2 MRM1 HPS1 ASTN2 KAZALD1 PTPN21 TJAP1 MAPKBP1 PIK3R5	8.35e-05	196	208	9	1479_UP
Drug	Hexestrol [84-16-2]; Up 200; 14.8uM; HL60; HT_HG-U133A	CCDC81 DCN ASTN2 KAZALD1 KALRN TNC TMEM51 GRM4 SMTN	8.35e-05	196	208	9	2515_UP
Drug	Deptropine citrate [2169-75-7]; Up 200; 7.6uM; HL60; HT_HG-U133A	BNC2 FBXL18 PLXNA1 RANBP10 TNC CREB5 SMTN PTOV1 RNF6	8.35e-05	196	208	9	3144_UP
Drug	Perhexiline maleate [6724-53-4]; Down 200; 10.2uM; PC3; HT_HG-U133A	MRM1 HPS1 FAT4 TNC PTPN21 RNF6 ZNF839 PPP6R2 CSPP1	8.35e-05	196	208	9	5081_DN
Drug	NS-105	CHAT GRM4 GRM7	8.60e-05	10	208	3	CID000198695
Drug	SB 203580; Up 200; 1uM; PC3; HT_HG-U133A	MRM1 INO80D KAZALD1 DNMBP PLXNA1 BRWD1 FAM13A RNF6 CDK13	8.69e-05	197	208	9	7066_UP
Drug	Famotidine [76824-35-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A	KAZALD1 NKTR HSD17B1 RANBP10 RNF31 SMTN EFNA5 EGR1 PPP6R2	8.69e-05	197	208	9	1529_DN
Drug	SC-58125; Up 200; 10uM; HL60; HG-U133A	BNC2 SLCO3A1 BRINP1 BPIFA1 HPS1 ROCK2 HGSNAT EFNA5 FAM13A	8.69e-05	197	208	9	542_UP
Drug	Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A	PIDD1 INO80D CARD14 HSPG2 KALRN GSAP PTPN21 ARR3 EGR1	8.69e-05	197	208	9	2328_UP
Drug	Ganciclovir [82410-32-0]; Down 200; 15.6uM; PC3; HT_HG-U133A	UNC5B NAV3 PLXNA1 RANBP10 GSAP COL18A1 PCNX1 AKAP13 LSM14A	8.69e-05	197	208	9	6289_DN
Drug	Oxolinic acid [14698-29-4]; Up 200; 15.4uM; PC3; HT_HG-U133A	ABL1 PIDD1 ITGA2 INO80D HPS1 ASTN2 FAT4 SLITRK5 PCNX1	8.69e-05	197	208	9	2103_UP
Drug	Practolol [6673-35-4]; Up 200; 15uM; MCF7; HT_HG-U133A	PIDD1 SLCO3A1 CHAT MTMR3 COL14A1 FRMPD1 KMT2D ARR3 DCHS1	8.69e-05	197	208	9	5664_UP
Drug	ICI 182,780; Up 200; 0.01uM; HL60; HT_HG-U133A	BNC2 SLCO3A1 DCN FASN KMT2A KAZALD1 HSD17B1 GRM4 TSKU	9.03e-05	198	208	9	6197_UP
Drug	Triamterene [396-01-0]; Down 200; 15.8uM; PC3; HT_HG-U133A	NAV3 BRWD1 ROCK2 TSKU NCOR1 EFNA5 GTF3C2 SLITRK5 PPP6R2	9.03e-05	198	208	9	7307_DN
Drug	Thalidomide [50-35-1]; Up 200; 15.4uM; HL60; HG-U133A	FBXL18 CCNA1 FAM149B1 WDR44 DRP2 SIPA1 GTF3C2 EGR1 MINDY1	9.03e-05	198	208	9	1411_UP
Drug	Levopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; PC3; HT_HG-U133A	CD2BP2 HPS1 BRWD1 TMEM51 RNF6 SLITRK5 QSER1 ZNF839 CSPP1	9.03e-05	198	208	9	5083_DN
Drug	Atracurium besylate [64228-81-5]; Down 200; 3.2uM; PC3; HT_HG-U133A	NKTR PLXNA1 TNC MADD EXOC5 GTF3C2 NINL AKAP13 AP4M1	9.03e-05	198	208	9	1824_DN
Drug	Ciprofloxacin hydrochloride [93107-08-5]; Up 200; 10.8uM; MCF7; HT_HG-U133A	PODNL1 SPAG8 MAGI2 HPS1 HSPG2 DRP2 TMEM51 CDK13 TJAP1	9.03e-05	198	208	9	1522_UP
Drug	Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; PC3; HT_HG-U133A	PIDD1 CHAT HPS1 MDFIC DRP2 GRM4 RNF6 CSPG4 PCNX1	9.03e-05	198	208	9	4681_UP
Drug	Methacycline hydrochloride [3963-95-9]; Down 200; 8.4uM; PC3; HT_HG-U133A	UNC5B PIDD1 HPS1 ASTN2 E2F1 PTPN21 EGR1 LSM14A PPP6R2	9.03e-05	198	208	9	4062_DN
Drug	Triamcinolone [124-94-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A	KMT2A FAM149B1 PRRC2B RNF31 LAMA5 PTPN21 TJAP1 MINDY1 HTT	9.38e-05	199	208	9	7192_DN
Drug	Domperidone maleate; Down 200; 7.4uM; MCF7; HT_HG-U133A	MRM1 INO80D HPS1 ASTN2 MADD SMTN RASSF8 PPP6R2 CSPP1	9.38e-05	199	208	9	5701_DN
Drug	DAPH; Up 200; 10uM; PC3; HG-U133A	TSC1 INO80D PRRC2B WIPF1 CCNE1 EFNB2 FAM13A MAPKBP1 MINDY1	9.38e-05	199	208	9	578_UP
Drug	Lisuride (S)(-) [18016-80-3]; Down 200; 11.8uM; HL60; HG-U133A	CDCA3 NCAPG HPS1 ROCK2 ACIN1 PCNX1 AKAP13 ZNF839 HTT	9.38e-05	199	208	9	2046_DN
Drug	Nialamide [51-12-7]; Down 200; 13.4uM; PC3; HT_HG-U133A	DCN NAV3 CCNA1 ASTN2 KAZALD1 WIPF1 TNC AKAP13 RASSF8	9.75e-05	200	208	9	4525_DN
Disease	Liver carcinoma	CDCA3 TSC1 DCN FASN ARID1B NCAPG FBXL18 PPP4R3C CCNA1 KMT2A TIMD4 E2F1 CCNE1 EGR1 CSPG4	2.80e-06	507	204	15	C2239176
Disease	Van Maldergem Wetzburger Verloes syndrome	FAT4 DCHS1	4.76e-05	2	204	2	C1832390
Disease	Van Maldergem syndrome	FAT4 DCHS1	4.76e-05	2	204	2	cv:C1832390
Disease	Periventricular gray matter heterotopia	FAT4 DCHS1	4.76e-05	2	204	2	C1849173
Disease	Bladder Neoplasm	TSC1 KMT2A CHD6 CCNE1 NCOR1 KMT2D MAPK15	5.63e-05	140	204	7	C0005695
Disease	Malignant neoplasm of urinary bladder	TSC1 KMT2A CHD6 CCNE1 NCOR1 KMT2D MAPK15	5.89e-05	141	204	7	C0005684
Disease	Heterotopia, Periventricular, Autosomal Recessive	FAT4 DCHS1	1.42e-04	3	204	2	C1842563
Disease	vital capacity	BNC2 UNC5B MTMR3 ASTN2 PLXNA1 MOV10 MROH9 HSPG2 FRMPD1 GRM7 CREB5 ADAMTS10 NCOR1 EFNA5 FAM13A GUSB DLEU7 LRBA MAPKBP1 PPP6R2 TNXB	1.43e-04	1236	204	21	EFO_0004312
Disease	Malignant neoplasm of breast	XIRP1 ABL1 FSCB FASN ARID1B MTMR3 ASTN2 HERC2 ANK2 KALRN FRMPD1 E2F1 CCNE1 NCOR1 KMT2D PBRM1 TRAPPC12 ZFYVE26 LRBA	1.81e-04	1074	204	19	C0006142
Disease	Neoplasm of uncertain or unknown behavior of breast	ARID1B HERC2 NCOR1 PBRM1	1.84e-04	41	204	4	C0496956
Disease	Breast adenocarcinoma	ARID1B HERC2 NCOR1 PBRM1	1.84e-04	41	204	4	C0858252
Disease	Sarcomatoid Renal Cell Carcinoma	PIDD1 TSC1 NAV3 TFE3 PBRM1 AKAP13	2.73e-04	128	204	6	C1266043
Disease	Chromophobe Renal Cell Carcinoma	PIDD1 TSC1 NAV3 TFE3 PBRM1 AKAP13	2.73e-04	128	204	6	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	PIDD1 TSC1 NAV3 TFE3 PBRM1 AKAP13	2.73e-04	128	204	6	C1266044
Disease	Papillary Renal Cell Carcinoma	PIDD1 TSC1 NAV3 TFE3 PBRM1 AKAP13	2.73e-04	128	204	6	C1306837
Disease	Renal Cell Carcinoma	PIDD1 TSC1 NAV3 TFE3 PBRM1 AKAP13	2.73e-04	128	204	6	C0007134
Disease	waist-hip ratio	C2orf69 NUP85 SLCO3A1 KCNB2 BIRC6 PKD1 NAV3 ASTN2 COL14A1 SIPA1 TRIM7 CCNE1 ADAMTS10 COL18A1 PBRM1 FAM13A DLEU7 PCNX1 MAPKBP1 HTT	3.51e-04	1226	204	20	EFO_0004343
Disease	Colorectal Carcinoma	EPHB6 BRINP1 KCNB2 FBXO30 NCAPG MYLK3 ABCD3 ANK2 KALRN PPOX SMTN DCHS1 ACIN1 PIK3R5	4.07e-04	702	204	14	C0009402
Disease	tonsillectomy risk measurement	OR2J2 ANAPC1 PXDNL CD2BP2 MTMR3 PPP6R2 CSPP1 TNXB	4.79e-04	260	204	8	EFO_0007924
Disease	Squamous cell carcinoma of esophagus	FASN FAT4 KMT2D RNF6 TNXB	5.26e-04	95	204	5	C0279626
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	PIDD1 TSC1 NAV3 TFE3 PBRM1 AKAP13	5.92e-04	148	204	6	C0279702
Disease	hippocampal atrophy	MAGI2 CHD6 COL18A1 EFNA5	6.15e-04	56	204	4	EFO_0005039
Disease	unipolar depression, bipolar disorder	BRINP1 PXDNL STARD9 ASTN2 FAT4 EFNA5	7.80e-04	156	204	6	EFO_0003761, MONDO_0004985
Disease	lung small cell carcinoma (is_implicated_in)	E2F1 KMT2D PBRM1	9.39e-04	28	204	3	DOID:5409 (is_implicated_in)
Disease	centronuclear myopathy (implicated_via_orthology)	KLHL31 MTMR6	9.76e-04	7	204	2	DOID:14717 (implicated_via_orthology)
Disease	intellectual disability (is_implicated_in)	TSC1 ARID1B CDK13	1.15e-03	30	204	3	DOID:1059 (is_implicated_in)
Disease	corneal resistance factor	ABL1 CRACR2B ITGA2 DCN ANAPC1 KMT2A KAZALD1 HERC2 MROH9 AKAP13	1.25e-03	451	204	10	EFO_0010067
Disease	body weight	C2orf69 BRINP1 KCNB2 POLR1G OTUD7B FASN PKD1 MTMR3 ASTN2 PLXNA1 MDFIC GRM7 CCNE1 ADAMTS10 NCOR1 DNAH12 EGR1 GUSB DLEU7	1.26e-03	1261	204	19	EFO_0004338
Disease	osteosarcoma	GRM4 DLEU7	1.30e-03	8	204	2	EFO_0000637
Disease	sialic acid-binding Ig-like lectin 12 measurement	SIGLEC12 KALRN	1.30e-03	8	204	2	EFO_0802066
Disease	centronuclear myopathy X-linked (implicated_via_orthology)	MTMR3 MTMR6	1.66e-03	9	204	2	DOID:0111225 (implicated_via_orthology)
Disease	breast cancer (is_marker_for)	TSC1 CCNE1 KMT2D MAPK15 EGR1 CDK13	1.87e-03	185	204	6	DOID:1612 (is_marker_for)
Disease	visceral adipose tissue measurement	BNC2 RIPOR2 UBQLN4 KCNB2 MAGI2 PKD1 COL14A1 CCNE1 SLITRK5 HTT	2.01e-03	481	204	10	EFO_0004765
Disease	tenascin measurement	TNC TNXB	2.06e-03	10	204	2	EFO_0008296
Disease	1,7-dimethylurate measurement	ITGA2 MDFIC	2.06e-03	10	204	2	EFO_0021512
Disease	adseverin measurement	C1R DNMBP	2.06e-03	10	204	2	EFO_0801358
Disease	chronic obstructive pulmonary disease, chronic bronchitis	CRACR2B FAM13A	2.06e-03	10	204	2	EFO_0000341, EFO_0006505
Disease	guanosine diphosphate measurement	KCNB2 NINL	2.51e-03	11	204	2	EFO_0010494
Disease	sleep disorder (implicated_via_orthology)	TFAP2E INSRR	2.51e-03	11	204	2	DOID:535 (implicated_via_orthology)
Disease	osteosarcoma (is_marker_for)	E2F1 EGR1	2.51e-03	11	204	2	DOID:3347 (is_marker_for)
Disease	amino acid measurement	BCAT2 ITGA2 NAV3 ASTN2 COL14A1 MTUS2 FAT4 GRM7 DNAH12 LRCH4 LRBA HTT	2.82e-03	678	204	12	EFO_0005134
Disease	Carcinoma, Transitional Cell	KMT2A CHD6 NCOR1	2.86e-03	41	204	3	C0007138
Disease	intracranial aneurysm (is_implicated_in)	PKD1 KMT2D	3.00e-03	12	204	2	DOID:10941 (is_implicated_in)
Disease	waist-hip ratio, body mass index	MRM1 DOCK2	3.00e-03	12	204	2	EFO_0004340, EFO_0004343
Disease	intraocular pressure measurement	DCN ANAPC1 KMT2A KAZALD1 HERC2 MROH9 KALRN CSPG4 AKAP13 TNXB	3.01e-03	509	204	10	EFO_0004695
Disease	Reperfusion Injury	CHAT EFNA5 EFNB2 EGR1	3.43e-03	89	204	4	C0035126
Disease	cognitive impairment measurement	PXDNL NAV3 COL14A1	3.50e-03	44	204	3	EFO_0007998
Disease	sleep duration, low density lipoprotein cholesterol measurement	BCAT2 MAGI2 TIMD4 HTT	3.71e-03	91	204	4	EFO_0004611, EFO_0005271
Disease	esophagus squamous cell carcinoma (is_implicated_in)	COL14A1 KMT2D EFNB2	3.73e-03	45	204	3	DOID:3748 (is_implicated_in)
Disease	pulse pressure measurement	BNC2 BRPF3 SSPOP FASN ARID1B PXDNL PKD1 HSD17B1 ANK2 WIPF1 LAMA5 DDI2 SIPA1 GRM4 CREB5 MADD PBRM1 FAM13A AKAP13	3.79e-03	1392	204	19	EFO_0005763
Disease	hair colour measurement	BNC2 HERC2 PLXNA1 CREB5 KMT2D FAM13A NINL PCNX1 AKAP13 QSER1 CDH15	3.87e-03	615	204	11	EFO_0007822
Disease	urate measurement	BNC2 RIPOR2 UBQLN4 CCDC81 MCM6 BIRC6 PRRC2B CDC42BPG CCNE1 FAM13A TKT CSPG4 NINL AKAP13	3.94e-03	895	204	14	EFO_0004531
Disease	actinic keratosis	BNC2 HERC2	4.10e-03	14	204	2	EFO_0002496
Disease	autism spectrum disorder (implicated_via_orthology)	TSC1 BRINP1 ARID1B CHD6 LRBA	4.19e-03	152	204	5	DOID:0060041 (implicated_via_orthology)
Disease	sunburn	BNC2 ARID1B HERC2 FAM13A	4.49e-03	96	204	4	EFO_0003958
Disease	serum gamma-glutamyl transferase measurement	BCAT2 PKD1 KMT2A ASTN2 DNMBP KALRN RNF135 TWNK CREB5 PBRM1 EFNA5 AKAP13 LRBA PPP6R2	4.73e-03	914	204	14	EFO_0004532
Disease	cortical thickness	BNC2 RIPOR2 ARID1B PKD1 MTMR3 NAV3 KMT2A ASTN2 FNIP2 HSPG2 SPECC1 COL18A1 EFNA5 EFNB2 LSM14A QSER1	4.76e-03	1113	204	16	EFO_0004840
Disease	Endometrioma	ITGA2 C1R HSD17B1 TNC NCOR1	5.34e-03	161	204	5	C0269102
Disease	Endometriosis	ITGA2 C1R HSD17B1 TNC NCOR1	5.34e-03	161	204	5	C0014175
Disease	idiopathic scoliosis (implicated_via_orthology)	SSPOP PRMT5	5.35e-03	16	204	2	DOID:0060250 (implicated_via_orthology)
Disease	autosomal recessive polycystic kidney disease (implicated_via_orthology)	TSC1 PKD1	5.35e-03	16	204	2	DOID:0110861 (implicated_via_orthology)
Disease	body surface area	BNC2 BRPF3 KCNB2 MTMR3 ASTN2 CREB5 CCNE1 ADAMTS10 GUSB DLEU7 AKAP13	5.37e-03	643	204	11	EFO_0022196
Disease	central corneal thickness	ITGA2 DCN ANAPC1 KMT2A HERC2 MROH9 AKAP13	5.90e-03	309	204	7	EFO_0005213
Disease	Uveal Melanoma	UNC5B BRINP1 HERC2	5.92e-03	53	204	3	EFO_1000616
Disease	Huntington's disease (is_marker_for)	E2F1 NCOR1 HTT	5.92e-03	53	204	3	DOID:12858 (is_marker_for)
Disease	Familial thoracic aortic aneurysm and aortic dissection	PKD1 ADAMTS10 COL18A1	5.92e-03	53	204	3	C4707243
Disease	Heschl's gyrus morphology measurement	BNC2 KALRN PCNX1	5.92e-03	53	204	3	EFO_0005852
Disease	familial hyperlipidemia	BCAT2 POLR1G TIMD4 ZNF512	6.37e-03	106	204	4	MONDO_0001336
Disease	lymphocyte count	RIPOR2 ABL1 INSRR OR2J2 NIBAN3 FBXL18 ANAPC1 FNIP2 DOCK2 ROCK2 RANBP10 TIMD4 KALRN NCOR1 PBRM1 PCDHGA12 CDK13 DLEU7 HTT	6.44e-03	1464	204	19	EFO_0004587
Disease	factor VII measurement	FSCB GRM7 TSKU	6.56e-03	55	204	3	EFO_0004619
Disease	age at onset, Parkinson disease	DSG3 QSER1	6.77e-03	18	204	2	EFO_0004847, MONDO_0005180

Protein segments in the cluster

Peptide	Gene	Start	Entry
QLSPPNTDADTRELL	ACIN1	451	Q9UKV3
NELLPLSAPLQGLSE	DCANP1	51	Q8TF63
RTLDLGENQLETLPP	LRG1	191	P02750
ALQESLQLSTEPRGP	ANKRD13D	536	Q6ZTN6
ETLLQSIDLPPLNSA	BIRC6	1936	Q9NR09
PQGATLRLDPTVLDA	CSPG4	2056	Q6UVK1
PGADPQRSNELLLLA	C2orf69	61	Q8N8R5
PTLLRNETGQGPVDL	BRINP1	626	O60477
EQPGLRLREPSLSTQ	BNC2	346	Q6ZN30
NDPDLLPNITLGARI	GRM4	91	Q14833
NPSTGDIVISRPLNR	FAT4	2821	Q6V0I7
ALSSGTLQEEQRTPP	AKAP13	941	Q12802
SEQNRASPLPSGLLT	CCNE1	381	P24864
PASRGVTQRLDLPDL	SPECC1	876	Q5M775
SLALTPRPQLELAES	DPH2	431	Q9BQC3
SPLQLGNEPLQRLLS	BRPF3	886	Q9ULD4
LPQEGSLARIPETSL	DNMBP	311	Q6XZF7
QQERPSSLPDLSGSI	ARID1B	741	Q8NFD5
GPNSVLSPQRLVLET	ARID1B	2141	Q8NFD5
GRLPSIPENRNLTEL	DENND1C	181	Q8IV53
LELENSVTLGPNLLP	C1R	561	P00736
LDDSRTNTPQGVLPS	CDK13	1051	Q14004
ESSSPQGPLTVLQER	ARR3	86	P36575
QRQPLLATLSSVPGA	ARRDC1	341	Q8N5I2
EIGQLQPPLRSTSAG	ASTN2	366	O75129
DQESLLLEGLPGTPQ	ADAMTS10	751	Q9H324
QDRSPLGNSRPALIL	TFAP2E	361	Q6VUC0
LPRGVVSLSQELSSP	AP4M1	336	O00189
LGRSPLTILQDDNSP	CDCA3	196	Q99618
EPSQILSLTGDRVPL	NUP43	206	Q8NFH3
QPLSLDSREARGQIP	MTUS2	196	Q5JR59
PGSSRQLPSNLRILQ	RASSF8	391	Q8NHQ8
LRILQNPISSGFNPE	RASSF8	401	Q8NHQ8
GLPSPGEQELSRRLQ	RANBP10	26	Q6VN20
PLLRLNQVSPADSGE	HSPG2	2876	P98160
ERLGSSVLSNSIPPQ	QSER1	116	Q2KHR3
LVLTGLTQIPTANPD	INTS9	261	Q9NV88
VPENSPRGTLIALLN	PCDHGA12	356	O60330
SPLEEATLQLPLGSE	KCTD19	661	Q17RG1
SLRNVGTQTLPARPL	CDC42BPG	711	Q6DT37
PSGALLQVLDLRDPQ	CDC42BPG	991	Q6DT37
SRELGPQEPTGSQLL	NIBAN3	76	Q86XR2
RNQLSTLPEELGDLP	LRCH4	191	O75427
NLTGRAPPRNTTVDL	ANAPC1	1106	Q9H1A4
PPLNEGESLVSRILQ	ANK2	1051	Q01484
VDPTSQRLLPLATTG	OTUD7B	176	Q6GQQ9
NRQIGPVPGSLSSLL	CREB5	151	Q02930
ATSALLRAQEQIPPG	DSG3	546	P32926
QGSPPRSASLQLLVQ	DCHS1	1296	Q96JQ0
VLLRENNPPGTSLLT	DCHS1	1656	Q96JQ0
NNPPGTSLLTLRATD	DCHS1	1661	Q96JQ0
TQAELPRGSIPRSLE	MCM6	211	Q14566
SLPQLQTPLASELDL	PBRM1	1341	Q86U86
PSIQRVDLNDISPLG	KLHL31	106	Q9H511
VDRITSSEQPGLPLQ	MYF5	211	P13349
LTPDQLNSTGIPQLR	KAZALD1	271	Q96I82
LLLGRPSNDLQSTPS	MADD	456	Q8WXG6
LLNVTDQILPGATPS	MAGI2	196	Q86UL8
SDGELIRTQPQRLPQ	MDFIC	66	Q9P1T7
PSVELLGEIRSPSAQ	FSCB	376	Q5H9T9
QTLLGPLQQERSFPI	DLEU7	136	Q6UYE1
LPVNDALRTIEGSSP	MTMR6	576	Q9Y217
QLDDVSQPPGSLSSR	RPS6KC1	311	Q96S38
NERSAQGTSAPLLPL	HERC2	326	O95714
PRQNSAPLLQTALLG	MAPK15	411	Q8TD08
LDLSRNTISEIPPGI	LRRC39	111	Q96DD0
GLESRTQQPSLTPLS	EGR1	276	P18146
NNGSEPSDIIIPLRT	EFNB2	281	P52799
PTLLIGSPLSLQDGQ	PCNX1	806	Q96RV3
QEGSPILRDLVLSPN	PLXNA1	481	Q9UIW2
PILSPGNTQTLTELE	NUP85	241	Q9BW27
PETPSENLRTGLELA	MYLK3	251	Q32MK0
RIADTNITSIPQGLP	DCN	206	P07585
SATLPQESPALLQLR	NAV3	2301	Q8IVL0
VQLEARTPLPRGTDN	COL18A1	1486	P39060
PVPSQNEDLRSGLSS	CSPP1	506	Q1MSJ5
VLQRPLSPGNSESLT	KALRN	481	O60229
GEDLIQQLRSAPPSL	KALRN	701	O60229
TNEPPTGLRLNLLQS	DNAH12	2606	Q6ZR08
VGQETLPRDSPDLLL	NELFB	326	Q8WX92
QQQPRGPLGLTDLEL	MINDY1	401	Q8N5J2
IRSFGQTPSQLLIEP	LRBA	2471	P50851
QLSQGRSSPQLDPLR	LSM14A	176	Q8ND56
ALNQSTGLPTLTLPR	TWNK	271	Q96RR1
SIADLQSQLRSPLGP	LAMA5	2211	O15230
TSSIPQLLVNLRGPE	OR2J2	76	O76002
NALSSLNVLRPGEIP	PAXBP1	206	Q9Y5B6
GQTLLPPLLTDFVQS	MROH9	246	Q5TGP6
VLQPELSDGIPQLSL	FAM13A	296	O94988
LRVDISLENPGTSPA	ITGA2	756	P17301
LSNLPPSESRDLLNQ	DQX1	676	Q8TE96
ALNGLSLSRVPLPDE	PTPN21	856	Q16825
PQQLLTTLGPLFRNS	PTOV1	146	Q86YD1
SDGSVILRSQIPPDR	PPP4R3C	46	Q6ZMV5
RGLVLQPLLPQTQDS	OSCAR	256	Q8IYS5
NQLTTVPAGLPRTLA	PODNL1	276	Q6PEZ8
NDNRPELLLSSLTSP	PCDHB7	341	Q9Y5E2
ESQALRDPSVPRGLL	PXDNL	906	A1KZ92
GQPSSPQRLDRLSGL	CD2BP2	191	O95400
SNLEARNLGPRLTPL	GSAP	581	A4D1B5
RNLGPRLTPLLQEED	GSAP	586	A4D1B5
IRQRTNLPLGPSIDT	EXOC5	391	O00471
QPGEQLLSPERRTNT	HTT	2321	P42858
LLEETPSQGDRPLLG	KCNB2	756	Q92953
TDPQLLELGLVQSPD	BPIFA1	111	Q9NP55
LESSLQPVSPGRLDV	CARD14	536	Q9BXL6
PSQSLLSLEQEPLLS	E2F1	346	Q01094
IPGLDEANTSPRLSQ	DOCK2	1771	Q92608
DLGRQVLPTLPSLSQ	CCDC81	11	Q6ZN84
ELDQGLTNPSLRSPE	CHD6	211	Q8TD26
TLPSSGPQNLRVSEE	COL14A1	826	Q05707
PSQILPLSQDLDGIA	FRMPD1	986	Q5SYB0
GSLEVELPLPRSQSI	FNIP2	921	Q9P278
PPGSLETLQLDVRDS	HSD17B1	56	P14061
ADISNLVQVGPLPSR	GUSB	151	P08236
QDPPQRTVLGLLTAN	CCNA1	76	P78396
GLQSDLPLTPEQLEA	CRACR2B	56	Q8N4Y2
RGAVSTLLQAPELPT	ABL1	516	P00519
NRPGPQTRSDLLLSG	PRMT5	61	O14744
SLDIQSPPNIGLRRS	BRWD1	696	Q9NSI6
DLRQLETLAPSLQDP	MAPKBP1	871	O60336
PLSRTQEPGVTLASL	INSRR	551	P14616
LDENLLRSATLSNPP	INO80D	731	Q53TQ3
GENAAQTPRIPSRLL	EFNA5	201	P52803
SDPNLLPNVTLGARI	GRM7	91	Q14831
NPRLLGTPDIGSISN	KMT2A	3366	Q03164
LINSELGSPSRTDPL	HGSNAT	236	Q68CP4
DIISPTSILPGQRNS	ENAM	921	Q9NRM1
NTGFQEESIPILTRP	CCDC168	5216	Q8NDH2
TSSPQGLDNPALLRD	DDI2	126	Q5TDH0
QLREIIPSSALPNGT	FBXO30	336	Q8TB52
QLNLRSLLVNPEGPT	FASN	2216	P49327
QGINLVLLTRSPSAP	HPS1	376	Q92902
EPTLPANLSTRLGQT	B3GNT8	51	Q7Z7M8
NEPSLGVSQPTRALL	BCAT2	176	O15382
RPTLNELGISTPEEL	COX5A	131	P20674
GELLARPEALTPSNL	SPACA6	281	W5XKT8
RLSLLLRDSGQPPQQ	CDH15	556	P55291
TATLLNTRPLQDLSP	CNTROB	141	Q8N137
RELLLQPPTESDGSG	DRP2	871	Q13474
GSQLQEALEPDPLLT	PPP6R2	226	O75170
LSSLQVPPRGEDSLE	MTMR3	776	Q13615
LSQNLLDTLPPEIGG	PIDD1	201	Q9HB75
LNRSLAITLPEPNGS	PKD1	2566	P98161
PDLLSDPSIVGSNLR	PKD1	3421	P98161
SRLNETQPIDLSGLP	RNF180	256	Q86T96
LSRNNLLPPIGTAEV	FAM149B1	466	Q96BN6
LGQGSSPEPELLRSQ	GAREM2	706	Q75VX8
LQRLIPGSNLDSEPR	GOLM2	321	Q6P4E1
RPLSESGPDNELSIL	RNF135	156	Q8IUD6
RAPQLPGVSNIRTLD	SPAG8	416	Q99932
DPSQPIDLTQLVNGR	MRPL15	111	Q9P015
LTLTLEEQAQELPPG	SSPOP	4886	A2VEC9
STLTLDNLGRDPVPA	SLCO3A1	671	Q9UIG8
DVLGDQLLTRELPPN	LRRC27	276	Q9C0I9
SPLGNARLDTPDINI	NKTR	1146	P30414
DQNPRLLTLEVPGVT	MOV10	371	Q9HCE1
RQLPPGLESLNVSVA	MRM1	281	Q6IN84
VAQGRSSLPPNLEIR	PRDM15	406	P57071
RDLSSLQPLLSGLQP	FBXL18	771	Q96ME1
PQGELSSQLPERLSL	EPHB6	581	O15197
GTLRSLEPEPQQSLE	HID1	636	Q8IV36
PSVGSISLGLPRQQE	NCOR1	1081	O75376
RILEGPQQSLSGSPL	POLR1G	116	O15446
LRNPNNLVETGTLPI	RNF6	571	Q9Y252
TILESLSREGQPIPE	SIPA1	941	Q96FS4
QVSRPEVSAGSLLLP	SCOC	41	Q9UIL1
LTGQPRFPTLTNINE	MT-ND5	431	P03915
LLPVGPRVSSNLNLN	STARD9	1531	Q9P2P6
TRLPGNLSSEDVLPA	IL9R	381	Q01113
LPLLGTERDASQTQP	NINL	941	Q9Y2I6
SPSQSSNLGVLELPR	SIGLEC12	421	Q96PQ1
DQRLLASITPSPSGQ	SPRY3	96	O43610
PLPLTTGNESLDITI	RIPOR2	731	Q9Y4F9
PLATPNGDVLIRDLN	ABCD3	446	P28288
ETPSSPRAGQLLEVL	ACD	21	Q96AP0
SNEDERLPPIGLLTS	CHAT	341	P28329
LLVDLTRPSGLNPQA	NCAPG	801	Q9BPX3
QPRPQSTSLLALGDS	RNF31	276	Q96EP0
GTANLSEAIRVPPTL	SIRPB1	241	O00241
RQSLLPINRGTEEGP	TJAP1	496	Q5JTD0
GRTPQPDSALIRQAL	PPOX	206	P50336
QTGPLLGRPDSLELQ	RSPH3	206	Q86UC2
GSPPSDEIRTLRDQL	TSC1	681	Q92574
LDPDTANPRLILSLD	TRIM7	346	Q9C029
GSPLLQDISAERSPN	ZNF846	86	Q147U1
QLPSTLPVSGNLLDV	TFE3	291	P19532
ILDINRLGQSDPAPL	TKT	181	P29401
EAQALEGSPTQLPIL	PIK3R5	641	Q8WYR1
ENRGIISLSEISPPR	SLITRK5	66	O94991
PEQEPQLLSGIGRIS	TRAPPC12	576	Q8WVT3
VGLRLQTGTPQESLP	STPG3	66	Q8N7X2
LTTVPDGPTQLRALN	TNXB	3841	P22105
QNLTLPGSLRAVDIP	TNC	1391	P24821
RGEEQNPRLSISLPS	TMEM51	146	Q9NW97
SPIVARTDLSNIPGL	WDR44	96	Q5JSH3
SSQRIGQELLFPPQE	PRRC2B	821	Q5JSZ5
DPRSPINVESLLDGL	ROCK2	36	O75116
SGNDETPRLPQRNLS	WIPF1	326	O43516
NLLLAGEAPSTRPQR	RPS6KL1	286	Q9Y6S9
LVTTNRLSPQGNFLP	RFPL3	6	O75679
SQQLLGLPRDPGSSV	UNC5B	531	Q8IZJ1
GQINLSLLVPRGPSS	ZC3H12B	156	Q5HYM0
TLPSEPENGALLRSE	ZNF839	291	A8K0R7
ALGQLEQPEISISRP	TRGV11	16	A0A075B6L2
LQPLPLSGEGSRELE	ZBTB42	261	B2RXF5
SIPPSLNLRDLGLSE	YME1L1	111	Q96TA2
PTNSPLQRIRLSDGS	GTF3C2	586	Q8WUA4
LQELDLSGTNLVPLP	TSKU	281	Q8WUA8
LQTLQTEAPGLVPSL	UBQLN4	476	Q9NRR5
DPVTTPLRLITNQGR	UHRF1BP1	201	Q6BDS2
RRQQPGIELPETELS	ZNF512	506	Q96ME7
PPERLAALLAQENLS	ZFYVE26	1206	Q68DK2
DRLGSRPSLQEQSPL	XIRP1	201	Q702N8
RLQDGTPQAALSPLT	SMTN	346	P53814
PRGDVSLTILNPSES	TIMD4	91	Q96H15
PGQPTGQEELRSLVL	WDR81	336	Q562E7
LELVNRPPSSTELGR	KMT2D	2961	O14686
ISIPLSALQLPGQDE	KIAA1958	321	Q8N8K9